NCT03208231: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03208231 |
|---|---|
| Title | Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 With Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 6, 2018 |
| Completion date | June 16, 2020 |
| Required reporting date | June 16, 2023, midnight |
| Actual reporting date | April 27, 2023 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |